Abivax (ABVX) is up 16.1%, or $18.50 to $133.44.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABVX:
- Why Is Abivax (ABVX) Stock Rallying Today?
- – Abivax SA American Depositary Shares call volume above normal and directionally bullish
- Abivax to be added to Nasdaq Biotechnology Index
- Abivax price target raised to $175 from $150 at Guggenheim
- Abivax price target raised to $142 from $112 at Piper Sandler